Skip to main content
    I

    InMode Ltd (INMD)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $12.92
    -0.23 (-1.75%)

    Market Cap: $756.71M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    InMode Ltd (INMD) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    InMode (INMD) has a market cap of $756.71M and an enterprise value of $363.17M. Its share count is down 8.80% from a year earlier. It holds $393.54M more cash than debt, 52.01% of its market cap.

    Total Valuation

    Enterprise value is 52.01% below the market cap, as cash exceeds debt.

    Market Cap$756.71M
    Enterprise Value$363.17M
    Latest price (Nov 17, 2026)$12.92

    Key Dates

    The next earnings report is expected on Feb 8, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 8, 2027 (expected)
    Last Earnings DateNov 11, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 1.90% in the quarter ended Sep 30, 2026 and shrank 13.89% a year over 2 years.

    Shares Outstanding58.25M
    Shares Change (YoY)-8.80%
    Shares Change (QoQ)-1.90%
    Share Count Growth (2Y CAGR)-13.89%

    Valuation Ratios

    Sales and book value multiples are 2.0x and 1.2x. Its year-end P/E ranged from 8.7x to 34.4x from 2019 to 2025.

    P/E Ratio9.4x
    Forward P/E9.8x
    P/S Ratio2.0x
    Forward P/S2.0x
    P/B Ratio1.2x
    P/FCF Ratio10.5x
    P/OCF Ratio10.4x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 4.7x EBITDA and 5.0x free cash flow.

    EV / Earnings4.9x
    EV / Sales1.0x
    EV / EBITDA4.7x
    EV / FCF5.0x

    Price Statistics

    The stock is down 8.82% over 52 weeks and trades 7.85% below its 50-day average.

    Beta (1Y)0.72
    52-Week Change-8.82%
    1-Month Change-8.17%
    3-Month Change-14.10%
    6-Month Change-7.52%
    5-Year Change-86.05%
    Total Return (1Y)-8.82%
    Total Return (3Y CAGR)-16.37%
    Total Return (5Y CAGR)-32.58%
    Return vs SPY (1Y)-20.25%
    Max Drawdown (1Y)-23.23%
    Max Drawdown (3Y)-51.83%
    Sharpe Ratio (1Y)-0.30
    Correlation with SPY (1Y)0.32
    50-Day Average$14.02
    200-Day Average$14.25
    52-Week Range$12.72 to $16.67
    RSI (14 Days)37.2
    Average Volume (20 Days)640.58K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 8.58x current liabilities, and total debt is 0.01x shareholder equity.

    Current Ratio8.58x
    Quick Ratio7.65x
    Debt / Equity0.01x
    Debt / EBITDA0.05x
    Debt / FCF0.05x

    Returns and Efficiency

    Return on invested capital is 9.80% over the last 12 months, against a 5-year average of 25.53%.

    Return on Equity (ROE)11.44%
    Return on Assets (ROA)10.06%
    Return on Invested Capital (ROIC)9.80%
    ROE (5Y Average)26.68%
    ROA (5Y Average)23.56%
    ROIC (5Y Average)25.53%
    Asset Turnover0.51x
    Inventory Turnover1.21x
    Receivables Turnover5.88x
    Cash Conversion Cycle286 days

    Taxes

    Income tax took 14.89% of pretax income over the last 12 months.

    Income Tax (TTM)$13.04M
    Effective Tax Rate14.89%

    Scores

    INMD has an Altman Z-Score of 6.86, in the safe zone above 2.99, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score6.86
    Altman Z ZoneSafe
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $373.60M over the last 12 months is up 2.50% from the 12 months before.

    Revenue$373.60M
    Revenue Growth (YoY)+2.50%
    Gross Profit$286.16M
    Operating Income$65.81M
    Pretax Income$87.55M
    Net Income$74.51M
    Reported EPS (TTM)$1.37

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 87.95% of the $740.48M in total assets.

    Cash and Equivalents$397.11M
    Total Debt$3.58M
    Net Cash$393.54M
    Net Cash Per Share$6.76
    Working Capital$592.62M
    Shareholder Equity$651.22M
    Book Value Per Share$11.18
    Total Assets$740.48M
    Total Liabilities$89.26M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.15M of capital spending, operating cash flow left $71.66M of free cash flow.

    Operating Cash Flow$72.81M
    Capital Expenditures$1.15M
    Free Cash Flow$71.66M
    FCF Per Share$1.25
    Depreciation and Amortization$760.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 17.62%, against a 5-year average of 36.34%.

    Gross Margin76.60%
    Operating Margin17.62%
    Pretax Margin23.43%
    Net Margin19.94%
    FCF Margin19.18%
    Gross Margin (5Y Average)82.26%
    Operating Margin (5Y Average)36.34%
    Net Margin (5Y Average)38.63%

    Growth

    Revenue fell 6.57% a year over 3 years, and EPS 13.37% a year.

    Revenue Growth (3Y CAGR)-6.57%
    Revenue Growth (5Y CAGR)+12.44%
    EPS Growth (3Y CAGR)-13.37%
    EPS Growth (5Y CAGR)+8.31%
    FCF Growth (3Y CAGR)-22.35%
    FCF Growth (5Y CAGR)+1.36%
    Operating Income Growth (3Y CAGR)-24.43%
    Book Value Per Share Growth (2Y CAGR)+7.81%
    Tangible Book Per Share Growth (2Y CAGR)+7.81%

    Revenue and profit by year

    Dividends and Yields

    INMD does not pay a dividend. Its free cash flow yield is 9.52%.

    Earnings Yield10.64%
    FCF Yield9.52%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 2-for-1 forward split on Oct 1, 2021.

    Last Split DateOct 1, 2021
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 8 similar companies, INMD has the 8th highest P/E.

    P/E Ratio9.4x vs 27.2x median
    P/S Ratio2.0x vs 3.9x median
    ROIC9.80% vs -6.00% median
    Revenue Growth (Trailing 4 Quarters, YoY)+2.50% vs +14.21% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 0.77% and EPS growth at -7.29% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+0.77%
    EPS Growth Forecast (2Y CAGR)-7.29%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About INMD

    What is INMD's market cap?

    InMode has a market cap of $756.71M. Its enterprise value, which adds debt and subtracts cash, is $363.17M.

    What is INMD's P/E ratio?

    InMode has a trailing P/E ratio of 9.4x and a forward P/E of 9.8x.

    How many shares of INMD are outstanding?

    InMode has 58.25M shares outstanding. The count is down 8.80% from a year earlier.

    Does INMD pay a dividend?

    No. InMode does not pay a dividend.

    How much debt does INMD have?

    InMode has $3.58M of total debt and $397.11M of cash and equivalents, a net cash position of $393.54M.